It has become necessary to accept the clinical reality of therapeutic agents targeting the
cancer-associated immune system. In recent decades, several investigations have …

Nanoparticle-based therapeutics are poised to become a leading delivery strategy for
cancer treatment because they potentially offer higher selectivity, reduced toxicity, longer …

Cancer immunotherapy is emerging as a promising treatment modality that suppresses and
eliminates tumors by re-activating and maintaining the tumor-immune cycle, and further …

The complex tumor microenvironment is a most important factor in cancer development. The
biological microenvironment is composed of a variety of barriers including the extracellular …

Nanoscience has long been lauded as a method through which tumor-associated barriers
could be overcome. As successful as cancer immunotherapy has been, limitations …

We review recent progress in cancer nanomedicine, including stimulus-responsive drug
delivery systems and nanoparticles responding to light for phototherapy or tumor imaging. In …

Cancer is one of the biggest causes of mortality in the world. The advances in cancer
research have taken us to distance in understanding the disease, which helps develop …

Cancer immunotherapy is a promising cancer terminator by directing the patient's own
immune system in the fight against this challenging disorder. Despite the monumental …

Cancer immunotherapy and vaccine development have significantly improved the fight
against cancers. Despite these advancements, challenges remain, particularly in the clinical …

Recent mounting evidence has revealed extensive genetic heterogeneity within tumors that
drive phenotypic variation affecting key cancer pathways, making cancer treatment …